Understanding the effects of Medicare’s home health Quality of Patient Care Star Ratings: patient choice and unintended consequences
Project Number1R36HS026836-01A1
Contact PI/Project LeaderLI, JUN
Awardee OrganizationUNIVERSITY OF MICHIGAN AT ANN ARBOR
Description
Abstract Text
PROJECT SUMMARY
Nearly 3.5 million Medicare patients use home health care each year. However, the quality of home health
care is highly variable and has been a longstanding concern for US policy. Lower quality home health
agencies have poorer rates of compliance with clinical guidelines, poorer functional outcomes, and higher
rates of complications among its patients. Thus, Medicare has devoted significant resources toward
increasing transparency about the quality of care delivered by health care providers; policymakers hope that
providing easy-to-access, simplified quality information would enable patients to choose high quality care,
which then incentivizes providers to compete on quality. The home health Quality of Patient Care Star
Ratings program, one of several prominent national Star Ratings programs, is Medicare’s flagship initiative
to help patients find and choose high-quality home health agencies. It assigns agencies 5-star ratings in
half-star increments every quarter. Each rating summarizes an agency’s performance on several quality
measures relative to other agencies in the nation. For the program to achieve its goal, it must cause
consumers, including patients, families, or formal caregivers who act on behalf of patients, to choose higher
rated agencies. A small and growing body of literature suggests that the 5-star format succeeded at eliciting
meaningful consumer demand for high-performing providers in the nursing home and health plan sectors.
Despite the theoretical benefits of the program and promising findings in other sectors, no research exists
on the effectiveness or unintended consequences of the program for home health care. This study is the first
to estimate the causal implications of the program on patient admissions and access to care using a
regression discontinuity design. This dissertation encompasses three aims: 1) determine whether the
program succeeded in shifting patients toward higher rated agencies, 2) examine whether the program
affected patient admissions differently depending on the presence of low-quality or potentially fraudulent
agencies within a market, and 3) assess whether the program decreased access to higher rated agencies for
socially and clinically vulnerable patients. Specifically, I consider whether higher rated agencies leveraged
patient demand to their advantage—by increasing admissions of more profitable patients to the detriment
of those who are less profitable. The home health population fits squarely with AHRQ’s Priority
Populations: compared to the general Medicare population, home health patients are 30 percent more likely
to have incomes at or below 200 percent of the Federal Poverty Level, 36 percent more likely to have at
least three chronic conditions, and 80 percent more likely to report having fair or poor health. The outcome
of this dissertation provides a comprehensive understanding of the effects of the Star Ratings program on
patients, which is critical for policy refinement as policymakers grapple with finding solutions to achieve
better quality within the US health care system.
Public Health Relevance Statement
PROJECT NARRATIVE
The home health Star Ratings program is Medicare’s flagship initiative to help patients find high quality
home health care. The rationale underlying the program is that if patients choose high quality providers,
then providers are incentivized to compete on quality, leading to better quality overall. However, given that
no empirical evidence on the program’s effectiveness exists, this study has three aims: 1) determine whether
the program shifted patients into higher rated home health agencies, 2) assess whether the program’s effects
vary by the presence of low-quality or potentially fraudulent agencies within a market, and 3) determine
whether the program decreased access to higher rated agencies for vulnerable patients.
No Sub Projects information available for 1R36HS026836-01A1
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1R36HS026836-01A1
Patents
No Patents information available for 1R36HS026836-01A1
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1R36HS026836-01A1
Clinical Studies
No Clinical Studies information available for 1R36HS026836-01A1
News and More
Related News Releases
No news release information available for 1R36HS026836-01A1
History
No Historical information available for 1R36HS026836-01A1
Similar Projects
No Similar Projects information available for 1R36HS026836-01A1